跳至主要内容
临床试验/CTRI/2026/03/106322
CTRI/2026/03/106322尚未招募4 期

Comparison of the effect of the Neuro Muscular reversal agents, sugammadex and neostigmine on postoperative nausea and vomiting in patients undergoing surgeries under general anaesthesia

未提供1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2026年4月2日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
104
试验地点
1

研究概览

简要总结

After obtaining approval from the Clinical Trials Registry of India (CTRI), participant recruitment will commence in accordance with the predefined inclusion and exclusion criteria. A total of 104 participants will be enrolled and randomly allocated into two groups based on the study drugs. In group S patients will receive sugammadex 2mg/kg intravenous and group N patients will receive Neostigmine 50 mcg/kg with Glycopyrrolate 10 mcg/kg combination Intravenous, to reverse vecuronium induced neuromuscular blockage. The study objective is To compare the incidence of PONV, To compare severity of PONV, To compare the need for rescue anti emetics. To monitor adverse event if any.

(PONV: Post Operative Nausea and Vomiting)

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Either gender.
  • Patients under ASA grade I, II.
  • Patients scheduled for surgeries to be performed under general anaesthesia.
  • Patients willing to sign written informed consent.
  • Patients ready to comply with perioperative fasting guidelines and protocols.

排除标准

  • Patients with grossly impaired cardio-respiratory, hepatic, and renal function.
  • Patients with known allergy any of the study drugs.
  • Patient experienced significant desaturation during induction.

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Vrajkumar Maheshwari

Parul Institute of Medical Sciences and Research

研究点 (1)

Loading locations...

相似试验